有关专家近日呼吁,应尽快制定中药专利保护法规,以迎头赶上加入WTO的要求。据《中国医药报》报道,在中国,中药品种保护可以由多个厂家申报,并且几个厂家可以同时获得保护。因此,这种保护是非独立性的。据有关资料显示,仅“牛黄解毒片”就有150多家企业生产,“复方丹参片”有140家企业生产,“安宫牛黄丸” Experts recently called for the formulation of patent protection laws and regulations as soon as possible to catch up with the WTO accession requirements. According to “China Medical News” reported that in China, the protection of traditional Chinese medicines can be declared by multiple manufacturers, and several manufacturers can also be protected. Therefore, this protection is non-independent. According to relevant data, only “Niuhuang detoxification tablets” have more than 150 enterprises producing, “” compound Danshen tablets “has 140 enterprises producing,” Angong Niuhuang Wan "